logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Urinary Tract Infection

    Medications for Urinary Tract Infection

    FiltersReset Filters
    27 results
    • amikacin sulfate

      (Amikacin Sulfate)
      Qilu Pharmaceutical Co., Ltd.
      Usage: Amikacin Sulfate Injection is indicated for short-term treatment of serious infections from susceptible Gram-negative bacteria, including Pseudomonas and E. coli. It is effective in septicemia, respiratory infections, urinary tract infections, and mixed infections alongside staphylococci. Usage should be guided by susceptibility tests to reduce drug resistance.
    • ampicillin

      (Ampicillin)
      Civica, Inc.
      Usage: Ampicillin for Injection, USP is indicated for treating infections from susceptible bacterial strains, including respiratory tract infections, bacterial meningitis, septicemia, endocarditis, urinary tract infections, and gastrointestinal infections. It should be reserved for severe cases or patients unable to take oral forms after susceptibility testing.
    • ampicillin sodium

      (Ampicillin Sodium)
      Armas Pharmaceuticals Inc.
      Usage: Ampicillin for Injection, USP is indicated for treating infections caused by susceptible organisms in respiratory tract infections, bacterial meningitis, septicemia, endocarditis, urinary tract infections, and gastrointestinal infections. It is recommended for moderate to severe infections and should be guided by susceptibility testing when available.
    • azactam

      (AZTREONAM)
      E.R. Squibb & Sons, L.L.C.
      Usage: AZACTAM is indicated for treating infections caused by susceptible Gram-negative bacteria, including urinary tract, lower respiratory tract, septicemia, skin and skin-structure, intra-abdominal, and gynecologic infections. It is also used adjunctively in surgical management of infections. Concurrent therapy with other antimicrobials may be necessary in seriously ill patients.
    • cefazolin

      (cefazolin sodium)
      Sagent Pharmaceuticals
      Usage: Cefazolin for Injection is indicated for treating serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections during contaminated surgeries. Its use should be guided by culture and susceptibility data.
    • cefazolin

      (Cefazolin Sodium)
      Baxter Healthcare Corporation
      Usage: Cefazolin in Dextrose Injection is indicated for treating respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, and endocarditis in adults and pediatric patients. It is also used for perioperative prophylaxis to reduce infection risk during certain surgeries. Limitations include its efficacy in preventing rheumatic fever.
    • cefazolin

      (Cefazolin)
      Civica, Inc.
      Usage: Cefazolin for Injection, USP is indicated for treating serious infections, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, endocarditis, and for perioperative prophylaxis to reduce postoperative infections in high-risk surgical patients. It targets various susceptible bacteria such as S. aureus and E. coli.
    • cefazolin

      (Cefazolin)
      Civica, Inc.
      Usage: Cefazolin for Injection is indicated for treating serious infections caused by susceptible organisms, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, and endocarditis. It is also used for perioperative prophylaxis to reduce postoperative infection risk in contaminated surgeries.
    • cefazolin

      (Cefazolin)
      Hospira, Inc
      Usage: Cefazolin for injection is indicated for treating serious infections, including respiratory, urinary, skin, biliary, bone, joint, genital infections, septicemia, and endocarditis caused by susceptible organisms. It also serves as prophylaxis for certain surgical infections, particularly in high-risk patients.
    • cefazolin

      (Cefazolin)
      Sandoz Inc
      Usage: Cefazolin for injection is indicated for treating infections like respiratory, urinary, skin, biliary, bone and joint infections, septicemia, and endocarditis due to various susceptible organisms. It is also used for perioperative prophylaxis to reduce postoperative infection risks in certain surgical procedures.